Skip to main content
Log in
Get started
Back to campaigns
rfp

Non-canonical Amino Acids for in vitro Display Systems

Dec 4, 2025 Jun 10, 2026
103 days left

AstraZeneca aims to build a world class peptide discovery platform, combining **phage and mRNA display****technologies and amenable to the incorporation of a wide variety of non-canonical amino acids** (ncAAs) in those display systems, from ncAAs capable of forming covalent bonds to enable new chemistries in peptides, such as cyclization, to ncAAs which can introduce novel physicochemical properties, such as altered hydrophobicity, charge, or backbone rigidity, to manipulate peptide solubility, cellular uptake, or overall structural dynamics.

The team at AstraZeneca is seeking solutions for the efficient incorporation of ncAAs in phage and/or mRNA display systems that allow for thioether macrocycle cyclisation and/or efficient incorporation of a range of amino acids. Proposed solutions to this challenge should meet the following solution requirements to be considered for funding by AstraZeneca. The selected collaborator will need to provide AstraZeneca with reagents allowing for at least one of the following: 

  • Efficient incorporation of ncAAs allowing for thioether macrocycle cyclisation in a phage display system. This should go beyond the simple use of evolved tRNA synthetases and overcome some of the limitations of stop codon reprogramming
  • Efficient incorporation of ncAAs allowing for thioether macrocycle cyclisation in an mRNA display/cell free protein expression system
  • Incorporation of other types of ncAA such as but not limited to N-methylated amino acids, fluorosulphate-amino acid, Aib, in an mRNA display/cell free protein expression system

Submission InformationAstraZeneca invites applications from both academic and biotech organizations. Applicants should complete the submission form [ADD LINK] which should contain a brief, non‑confidential overview of your proposal, demonstrating how the RFP requirements are satisfied by your approach. Proposals should outline the resources required to solve the problem. Additional submission requirements are highlighted on page [NUMBER] of the submission form. To submit your proposal, please visit our website, register, and submit your application form under the appropriate Connect campaign. 

Access full details

See the full details and submit your response through Inpart Connect.

View in the application
Create a free account
Start submission

Submissions

Eligible submissions are limited to the following list of opportunity types:

Centers of excellence

Top tips for writing submissions for Connect Campaigns

We're always striving to improve our introduction rates so that we can start more conversations across industry and academia, in turn helping biotech companies, universities, startups and research organisations to secure more support and funding for their research.

Read more

Powered by

Inpart Connect
Connecting decision makers

Find out more about launching a campaign to match your company's requirements, get in touch with our team!

Run a campaign
Products
Connect
Deal
Get started
Network
About
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2026 Inpart Privacy policy Terms of use